Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Shareholders' Equity / (Deficit)

v3.24.1
Consolidated Statements of Shareholders' Equity / (Deficit) - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Gain / ( Loss)
Beginning balance at Dec. 31, 2020 $ (50,559) $ 33 $ 236,337 $ (286,929)  
Beginning balance (in shares) at Dec. 31, 2020   3,295,402      
Issuance of ordinary shares, net 68,162 $ 39 68,123    
Issuance of ordinary shares, net (in shares)   3,879,300      
Share-based compensation expense 4,319   4,319    
Issuance of warrants for ordinary shares 6,199   6,199    
Exercise of warrants for ordinary shares 15,289 $ 14 15,275    
Exercise of warrants for ordinary shares (in shares)   1,417,761      
Issuance of ordinary shares on conversion of exchangeable notes 98,388 $ 36 98,352    
Issuance of ordinary shares on conversion of exchangeable notes (in shares)   3,592,556      
Net Income (Loss) (91,564)     (91,564)  
Ending balance at Dec. 31, 2021 50,234 $ 122 428,605 (378,493)  
Ending balance (in shares) at Dec. 31, 2021   12,185,019      
Issuance of ordinary shares, net 441 $ 4 437    
Issuance of ordinary shares, net (in shares)   413,622      
Share-based compensation expense 4,758   4,758    
Cancellation of share options 17,350   17,350    
Net Income (Loss) (44,434)     (44,434)  
Unrealized income (loss) on available-for-sale securities (350)       $ (350)
Ending balance at Dec. 31, 2022 27,999 $ 126 451,150 (422,927) (350)
Ending balance (in shares) at Dec. 31, 2022   12,598,641      
Issuance of ordinary shares, net 1,034 $ 7 1,027    
Issuance of ordinary shares, net (in shares)   732,763      
Share-based compensation expense 784   784    
Issuance of ordinary shares on conversion of exchangeable notes 1,800 $ 2 1,798    
Issuance of ordinary shares on conversion of exchangeable notes (in shares)   167,599      
Net Income (Loss) (38,371)     (38,371)  
Unrealized income (loss) on available-for-sale securities 351       351
Ending balance at Dec. 31, 2023 $ (6,403) $ 135 $ 454,759 $ (461,298) $ 1
Ending balance (in shares) at Dec. 31, 2023   13,499,003